Lacey B Robinson - JoVE Visualize

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

The Lancet. Respiratory Medicine|November 13, 2023

Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.

The New England Journal of Medicine|June 5, 2023

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.

The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class AnalysisCosby A Stone, Lacey B Robinson, Lily Li, et al.

Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

The Lancet. Respiratory Medicine|November 13, 2023

Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.

The New England Journal of Medicine|June 5, 2023

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.

The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class AnalysisCosby A Stone, Lacey B Robinson, Lily Li, et al.

Pageof 4